Report Detail
Global Medical Non-ionic Contrast Agent Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4678477 |
- 26 February, 2026 |
- Global |
- 122 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Medical Non-ionic Contrast Agent market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Due to the improvement of the chemical structure, non-ionic contrast agents have two main advantages over ionic contrast agents: most of the adverse reactions of contrast agents are related to high osmosis and charging. The distinguishing feature of non-ionic contrast agents is low osmotic pressure. It is uncharged, so it will not destabilize the internal environment; non-ionic contrast agents have less impact on peripheral blood vessels, pulmonary circulation vessels and cardiac conduction systems, so there are fewer sequelae, and they can be used for cardiovascular angiography.
This report is a detailed and comprehensive analysis for global Medical Non-ionic Contrast Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Non-ionic Contrast Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Liters), and ASP (US$/Liter), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Non-ionic Contrast Agent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Non-ionic Contrast Agent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Braco, Bayer, Guerbet, Leriva, Yangtze River Pharmaceutical (Group), Jiangsu Chia Tai-Tianqing Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Hainan Poly Pharm, Beijing Beilu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Non-ionic Contrast Agent market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Iopamidol Injection
Iodixanol Injection
Iohexol Injection
Iopromide Injection
Other
Market segment by Application
CT Enhanced Scan
Neurography
Angiography
Arthrography
Other
Major players covered
GE Healthcare
Braco
Bayer
Guerbet
Leriva
Yangtze River Pharmaceutical (Group)
Jiangsu Chia Tai-Tianqing Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Hainan Poly Pharm
Beijing Beilu Pharmaceutical
Zhejiang Starry Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Non-ionic Contrast Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Non-ionic Contrast Agent, with price, sales quantity, revenue, and global market share of Medical Non-ionic Contrast Agent from 2021 to 2026.
Chapter 3, the Medical Non-ionic Contrast Agent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Non-ionic Contrast Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Non-ionic Contrast Agent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Non-ionic Contrast Agent.
Chapter 14 and 15, to describe Medical Non-ionic Contrast Agent sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Medical Non-ionic Contrast Agent Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Iopamidol Injection
- 1.3.3 Iodixanol Injection
- 1.3.4 Iohexol Injection
- 1.3.5 Iopromide Injection
- 1.3.6 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Medical Non-ionic Contrast Agent Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 CT Enhanced Scan
- 1.4.3 Neurography
- 1.4.4 Angiography
- 1.4.5 Arthrography
- 1.4.6 Other
- 1.5 Global Medical Non-ionic Contrast Agent Market Size & Forecast
- 1.5.1 Global Medical Non-ionic Contrast Agent Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Medical Non-ionic Contrast Agent Sales Quantity (2021-2032)
- 1.5.3 Global Medical Non-ionic Contrast Agent Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 GE Healthcare
- 2.1.1 GE Healthcare Details
- 2.1.2 GE Healthcare Major Business
- 2.1.3 GE Healthcare Medical Non-ionic Contrast Agent Product and Services
- 2.1.4 GE Healthcare Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 GE Healthcare Recent Developments/Updates
- 2.2 Braco
- 2.2.1 Braco Details
- 2.2.2 Braco Major Business
- 2.2.3 Braco Medical Non-ionic Contrast Agent Product and Services
- 2.2.4 Braco Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Braco Recent Developments/Updates
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Medical Non-ionic Contrast Agent Product and Services
- 2.3.4 Bayer Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Bayer Recent Developments/Updates
- 2.4 Guerbet
- 2.4.1 Guerbet Details
- 2.4.2 Guerbet Major Business
- 2.4.3 Guerbet Medical Non-ionic Contrast Agent Product and Services
- 2.4.4 Guerbet Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Guerbet Recent Developments/Updates
- 2.5 Leriva
- 2.5.1 Leriva Details
- 2.5.2 Leriva Major Business
- 2.5.3 Leriva Medical Non-ionic Contrast Agent Product and Services
- 2.5.4 Leriva Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Leriva Recent Developments/Updates
- 2.6 Yangtze River Pharmaceutical (Group)
- 2.6.1 Yangtze River Pharmaceutical (Group) Details
- 2.6.2 Yangtze River Pharmaceutical (Group) Major Business
- 2.6.3 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product and Services
- 2.6.4 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Yangtze River Pharmaceutical (Group) Recent Developments/Updates
- 2.7 Jiangsu Chia Tai-Tianqing Pharmaceutical
- 2.7.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
- 2.7.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
- 2.7.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
- 2.7.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
- 2.8 Jiangsu Hengrui Pharmaceuticals
- 2.8.1 Jiangsu Hengrui Pharmaceuticals Details
- 2.8.2 Jiangsu Hengrui Pharmaceuticals Major Business
- 2.8.3 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product and Services
- 2.8.4 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
- 2.9 Hainan Poly Pharm
- 2.9.1 Hainan Poly Pharm Details
- 2.9.2 Hainan Poly Pharm Major Business
- 2.9.3 Hainan Poly Pharm Medical Non-ionic Contrast Agent Product and Services
- 2.9.4 Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Hainan Poly Pharm Recent Developments/Updates
- 2.10 Beijing Beilu Pharmaceutical
- 2.10.1 Beijing Beilu Pharmaceutical Details
- 2.10.2 Beijing Beilu Pharmaceutical Major Business
- 2.10.3 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
- 2.10.4 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Beijing Beilu Pharmaceutical Recent Developments/Updates
- 2.11 Zhejiang Starry Pharmaceutical
- 2.11.1 Zhejiang Starry Pharmaceutical Details
- 2.11.2 Zhejiang Starry Pharmaceutical Major Business
- 2.11.3 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
- 2.11.4 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Medical Non-ionic Contrast Agent by Manufacturer
- 3.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Medical Non-ionic Contrast Agent Revenue by Manufacturer (2021-2026)
- 3.3 Global Medical Non-ionic Contrast Agent Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Medical Non-ionic Contrast Agent by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Medical Non-ionic Contrast Agent Manufacturer Market Share in 2025
- 3.4.3 Top 6 Medical Non-ionic Contrast Agent Manufacturer Market Share in 2025
- 3.5 Medical Non-ionic Contrast Agent Market: Overall Company Footprint Analysis
- 3.5.1 Medical Non-ionic Contrast Agent Market: Region Footprint
- 3.5.2 Medical Non-ionic Contrast Agent Market: Company Product Type Footprint
- 3.5.3 Medical Non-ionic Contrast Agent Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Medical Non-ionic Contrast Agent Market Size by Region
- 4.1.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2032)
- 4.1.2 Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2032)
- 4.1.3 Global Medical Non-ionic Contrast Agent Average Price by Region (2021-2032)
- 4.2 North America Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
- 4.3 Europe Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
- 4.4 Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
- 4.5 South America Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
- 4.6 Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
- 5.2 Global Medical Non-ionic Contrast Agent Consumption Value by Type (2021-2032)
- 5.3 Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
- 6.2 Global Medical Non-ionic Contrast Agent Consumption Value by Application (2021-2032)
- 6.3 Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2032)
7 North America
- 7.1 North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
- 7.2 North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
- 7.3 North America Medical Non-ionic Contrast Agent Market Size by Country
- 7.3.1 North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
- 7.3.2 North America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
- 8.2 Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
- 8.3 Europe Medical Non-ionic Contrast Agent Market Size by Country
- 8.3.1 Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Medical Non-ionic Contrast Agent Market Size by Region
- 9.3.1 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
- 10.2 South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
- 10.3 South America Medical Non-ionic Contrast Agent Market Size by Country
- 10.3.1 South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
- 10.3.2 South America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Medical Non-ionic Contrast Agent Market Size by Country
- 11.3.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Medical Non-ionic Contrast Agent Market Drivers
- 12.2 Medical Non-ionic Contrast Agent Market Restraints
- 12.3 Medical Non-ionic Contrast Agent Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Medical Non-ionic Contrast Agent and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Medical Non-ionic Contrast Agent
- 13.3 Medical Non-ionic Contrast Agent Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Medical Non-ionic Contrast Agent Typical Distributors
- 14.3 Medical Non-ionic Contrast Agent Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Medical Non-ionic Contrast Agent. Industry analysis & Market Report on Medical Non-ionic Contrast Agent is a syndicated market report, published as Global Medical Non-ionic Contrast Agent Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Non-ionic Contrast Agent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
